SOPHiA GENETICS S.A.SOPHNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank68
3Y CAGR-5.3%
5Y CAGR-20.4%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-5.3%/yr
Quarterly compound
5Y CAGR
-20.4%/yr
Recent acceleration
Percentile
P68
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 10.63% |
| Q2 2025 | -6.85% |
| Q1 2025 | -0.27% |
| Q4 2024 | 16.12% |
| Q3 2024 | -1.06% |
| Q2 2024 | -15.26% |
| Q1 2024 | -3.78% |
| Q4 2023 | 8.64% |
| Q3 2023 | 1.05% |
| Q2 2023 | -4.75% |
| Q1 2023 | 37.47% |
| Q4 2022 | -32.88% |
| Q3 2022 | 12.53% |
| Q2 2022 | -5.12% |
| Q1 2022 | 49.02% |
| Q4 2021 | -16.94% |
| Q3 2021 | 19.89% |
| Q2 2021 | 3.32% |
| Q1 2021 | 19.51% |
| Q4 2020 | 2.99% |
| Q3 2020 | 33.36% |
| Q2 2020 | -18.70% |
| Q1 2020 | 0.00% |